Anika Therapeutics Stock
Price
Target price
€10.00
€10.00
-
-
-
€18.48
11.06.25 / Frankfurt
WKN: 889120 / Symbol: ANIK / Name: Anika / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Loading data...
Your prediction
Anika Therapeutics Stock
With 7 Buy predictions and not the single Sell prediction the community is currently very high on Anika Therapeutics.
As a result the target price of 18 € shows a very positive potential of 80.0% compared to the current price of 10.0 € for Anika Therapeutics.
For the coming years our community has positive and negative things to say abot the Anika Therapeutics stock. Criterium "Brand" gathered the most positive votes but regarding "EBIT growth" there were negative voices in the community.
Pros and Cons of Anika Therapeutics in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Anika Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Anika Therapeutics | - | -0.990% | -23.077% | -57.983% | -35.484% | -51.456% | -68.354% |
| Krystal Biotech | 1.650% | 5.097% | 3.664% | -26.384% | -20.072% | 138.529% | - |
| Ardelyx Inc. | 2.360% | -0.341% | -0.062% | -47.844% | -35.186% | 460.432% | -41.491% |
| Evolus Inc | 3.530% | 3.529% | -0.565% | -16.981% | -16.190% | -20.000% | 86.441% |
Comments
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its price target lowered by analysts at Barrington Research from $20.00 to $19.00. They now have an "outperform" rating on the stock.
Show more
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics, Inc. (NASDAQ: ANIK) was upgraded by analysts at B. Riley to a "strong-buy" rating.
Show more
Ratings data for ANIK provided by MarketBeat
Anika Therapeutics, Inc. (NASDAQ: ANIK) is now covered by analysts at B. Riley. They set a "buy" rating and a $21.00 price target on the stock.
Show more
Ratings data for ANIK provided by MarketBeat